All In MedTech

Device Trial Radar · NCT03803059

Efficacy and Tolerability of SkinPen on Male and Female Subjects' Wrinkles of the Neck

A Single-Center Trial to Evaluate the Efficacy and Tolerability of SkinPen on Male and Female Subjects' Wrinkles of the Neck

Last checked: Nov 20, 2026Latest source record: Dec 1, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

35

Actual

Start

Jan 31, 2019

Primary completion

Jan 10, 2020

Study completion Jan 10, 2020

Sponsor

Lead sponsor
Bellus Medical, LLCNot on our public-company list
Sponsor type
Industry
First posted
Jan 14, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 35 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This single-center, the clinical trial is being conducted over the course of 90 days followed by 1-month and 6-month post-treatment visits in order to assess the efficacy and tolerability of the Sponsor's SkinPen device when used by men and women with the wrinkles of the neck.

Conditions

  • Wrinkles

Interventions

  • SkinPen PrecisionDevice

    Surgical instrument motors and accessories/attachments/Hydrogel

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Assessment of Wrinkle Severity Using the Lemperle Wrinkle Assessment ScaleTime frame: Day 1 and 3 Month Post Treatment

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The University of Texas Southwestern Medical Center

    Dallas, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.